Treatment for thyroid cancer
Cancer have changes in their (DNA) that make them different from normal cells. These changes mean that they behave differently. Cancer cells can grow faster than normal cells and sometimes spread. Targeted cancer drugs work by ‘targeting’ those differences that a cancer cell has.
Targeted drugs work in different ways. For example, they can:
stop cancer cells from dividing and growing
encourage the to attack cancer cells
stop cancers from growing
You might hear some targeted drugs called biological therapies.
Find out more about targeted cancer drugs
Doctors treat most thyroid cancers with surgery and radioactive iodine therapy. You might have targeted drugs for thyroid cancer if:
other treatments are not an option or no longer work
the cancer begins to grow outside of the thyroid gland or spread to another part of your body
Targeted drugs cannot cure thyroid cancer but they may help to control it and reduce symptoms.
Whether you are able to have one of these drugs might also depend on:
other treatments you have already had
whether your cancer has changes (mutations) in certain proteins or genes
Your doctor will discuss targeted drugs with you if they think this treatment could help you.
You might also have targeted drugs as part of a .
You might need a test using some of your cancer cells to find out whether the targeted treatment is likely to work. These tests look for changes (mutations) in certain genes. The tests you have depend on what type of thyroid cancer you have.
Your doctor might look for changes in the:
RET gene
BRAF gene
NTRK gene
They usually test a sample of your thyroid cancer from when you were first diagnosed. Or they may use a sample from your operation if you had one.
The results of the tests show whether a targeted cancer drug is suitable for you.
There are many different types of targeted drugs. We describe some of the drugs for thyroid cancer below. Your doctor can tell you whether any of these treatments are suitable for you. It depends on several factors including what type of thyroid cancer you have.
Read more about the types of thyroid cancer
Selpercatinib is a targeted drug that blocks a protein called RET. You might have selpercatinib if:
you have advanced thyroid cancer that has spread
your cancer cells have certain changes in the RET gene
For medullary thyroid cancer, you might have selpercatinib if:
the cancer cells have a change (mutation) in the RET gene
For all other types of thyroid cancer, you might have selpercatinib if:
the cancer cells have a RET gene fusion where the RET gene joins with another gene
radioactive iodine treatment is no longer helping, if it is a suitable treatment for you
Find out more about selpercatinib and its side effects
Larotrectinib is a type of targeted cancer drug called a histology independent therapy (HIT). It treats any type of cancer that has a certain gene change.
You might have it for any type of thyroid cancer if:
your cancer cells have a NTRK gene fusion – this means the NTRK gene has joined with another gene
the cancer has spread or you are unable to have surgery
you do not have other treatment options
The Scottish Medicines Consortium (SMC) have not approved larotrecrinib. So it is not routinely available in Scotland.
Read more about how the NHS decides to fund new treatments
Differentiated thyroid cancers include:
papillary thyroid cancer
follicular thyroid cancer
oncocytic thyroid cancer
Lenvatinib and sorafenib are targeted drugs called tyrosine kinase inhibitors (TKIs). Your doctor might offer you one of these drugs if you have differentiated thyroid cancer and:
it has spread outside your thyroid
radioactive iodine is no longer helping you
you have not had a TKI before or had to stop taking a TKI within 3 months because of side effects
Unlike some other targeted drugs, you do not need to have a specific gene change (mutation) in your cancer cells to have these drugs.
Find out more about lenvatinib and sorafenib and their side effects
Cabozantinib is a type of cancer growth blocker called a tyrosine kinase inhibitor (TKI). You might have it for medullary thyroid cancer if:
your cancer has spread outside the thyroid
you are unable to have surgery
Dabrafenib and trametinib are cancer growth blockers. They work by targeting certain proteins that help cancer cells grow.
You might have a combination of dabrafenib and trametinib for anaplastic thyroid cancer if:
your cancer has a BRAF gene change
you are unable to have surgery
Most of the targeted drugs for thyroid cancer are tablets or capsules that you take by mouth.
You should take the right dose, not more or less.
Talk to your specialist or advice line before you stop taking a cancer drug.
Everyone is different and the side effects vary from person to person. The side effects you have depend on:
which drug you have
whether you have it alone or with other drugs
the amount of drug you have (the dose)
your general health
A side effect may get better or worse during your course of treatment. Or more side effects may develop as the treatment goes on. For more information about the side effects of your treatment, go to the individual drug pages.
Targeted drug treatment can be difficult to cope with for some people. Your nurse will give you a number to call (advice line) if you have any problems at home.
Last reviewed: 28 Oct 2026
Next review due: 28 Oct 2029
There are many cancer drugs and cancer drug combinations. Search for the one you are looking for to understand more about how it works, how you have it, the side effects and other important information.
Possible treatments include surgery, radiotherapy, targeted drugs and chemotherapy. What treatment you have depends on your type and stage of thyroid cancer.
Practical and emotional support is available to help you cope with thyroid cancer.
The thyroid is a small butterfly shaped gland that makes and releases hormones. It’s found at the front of your neck in the lowest part.